TC
DMK

TFS Capital’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

TFS Capital’s Portfolio DMK Stock Details DMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-192
Closed -$53K – 1118
2015
Q1 		$53K Buy
+192
New +$82.9K 0.01% 928
2014
Q4 		– Sell
-144
Closed -$47K – 1186
2014
Q3 		$47K Sell
144
-58
-29% -$17K ﹤0.01% 1001
2014
Q2 		$68K Buy
+202
New +$79.3K 0.01% 1071

Other funds holding DMK

SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
Walleye Trading
Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
LOAMU
Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

TFS Capital's DMK Position: Q2 2015 in Review

TFS Capital sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q2 2015, closing a stake of 192 shares — an estimated $53K sold.

TFS Capital first reported a position in DMK in Q2 2014 and held it in 3 quarters. The position peaked at $68K in Q2 2014. 29 funds tracked by Wall St. Rank hold DMK as of Q2 2015.

  • TFS Capital reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q2 2015 after selling out during the quarter.
  • TFS Capital sold 192 DMK Pharmaceuticals Corporation Common Stock shares in Q2 2015, an estimated $53K.
  • TFS Capital first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q2 2014 and held it in 3 quarters.
  • TFS Capital's DMK Pharmaceuticals Corporation Common Stock position peaked at $68K in Q2 2014.
  • 29 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q2 2015.

Based on TFS Capital's 13F filing for Q2 2015, filed 5 Aug 2015.